Detail of the clinical trial
| Title of the trial | A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator?s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for platinum-based Chemotherapy-ineligible Elderly Patients with Locally Advanced Head & Neck Squamous Cell Carcinoma |
|---|---|
| EudraCT number | 2021-002163-22 |
| Protocol number | NANORAY-312 |
| Sponsor | NANOBIOTIX, 60 rue de Wattignies, 750 12 Paris, France |
| Indications | Oncology |
| Diagnosis | head and neck carcinoma |
| Population in clinical trial |
Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2021 |
| Date of approval by Institute (SÚKL) | 2.12.2021 |
| Date of approval by EC | 10.1.2022 |
| Date of initiation CT in ČR | 9.11.2022 |
| Date of ending CT in ČR | |
| Notice | |
| Sites |
Fakultní nemocnice Bulovka, Ústav radiační onkologie,Budínova 2,Praha 8,180 81 Fakultní nemocnice Olomouc, Onkologická klinika,I. P. Pavlova 185/6,Olomouc,779 00 |
cz